Verified

Cell culture media:

HEK Media

Tailored Solutions for Gene Therapy and Protein Production

Sartorius Stedim Biotech GmbH

Our high performing HEK media are designed to best fit with the high variability of HEK293 cell lines, the versatility of AAV and complexity of viral vector processes from early clinical phases to large commercial scale.

​Human embryonic kidney (HEK 293) cells and human cell lines are commonly used for Gene Therapy applications (AdenoAssociated Virus) , Gene Modified Cell therapy (Lentivirus), Viral vector Vaccines( Adenovirus) and Proteins production.

Suitable for HEK (e.g., HEK293) and other human cell lines for Infection & Stable expression in suspension

  • Chemically defined, serum-free, animal component-free, serum-free and hydrolysate-free
  • Little or no adaptation required from other serum-free media
  • Supports stable growth of suspension cells at high viability in seed train culture
  • Manufactured under ISO 9001 QMS (Quality Statement)

Product classification HEK Media

Request information about HEK Media now

Cell culture media: HEK Media

Tailored Solutions for Gene Therapy and Protein Production

Sartorius Stedim Biotech GmbH
All about Sartorius

Find HEK Media and related products in the theme worlds

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

2 products
5+ whitepaper
2 brochures
View topic world

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

2 products
5+ whitepaper
2 brochures

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.

View topic world

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.